Live Breaking News & Updates on Astellas Pharma Company Profile Get Rating

Stay updated with breaking news from Astellas pharma company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Critical Contrast: Astellas Pharma (OTCMKTS:ALPMY) vs. Thorne HealthTech (NASDAQ:THRN)

Astellas Pharma (OTCMKTS:ALPMY – Get Rating) and Thorne HealthTech (NASDAQ:THRN – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Analyst Ratings This is a summary of recent recommendations and […] ....

New York , United States , Betanis Myrbetriq , Astellas Pharma , Thorne Healthtech , Harnal Omnic , Advagraf Graceptor , Minovia Therapeutics Ltd , Cytokinetics Incorporated , Thorne Healthtech Inc , Zenith Epigenetics Ltd , Cytomx Therapeutics Inc , Entertainment Inc , Merck Co Inc , Astellas Pharma Inc , Harvard University , Actinium Pharmaceuticals Inc , Thorne Healthtech Company Profile Get Rating , Astellas Pharma Company Profile Get Rating , Get Rating , Given Thorne Healthtech , Pharma Company Profile , Cytomx Therapeutics , Actinium Pharmaceuticals , Antibody Warhead Enabling , Zenith Epigenetics ,

Astellas Pharma Inc. (OTCMKTS:ALPMY) Short Interest Down 85.3% in May

Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Rating) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 3,300 shares, a drop of 85.3% from the May 15th total of 22,400 shares. Based on an average daily volume of 136,900 shares, the […] ....

Betanis Myrbetriq , Astellas Pharma , Advagraf Graceptor , Jefferies Financial Group , Astellas Pharma Inc , Zacks Investment Research , Astellas Pharma Company Profile Get Rating , Get Rating , Financial Group , Pharma Company Profile , Pharma Inc , Otcmkts Alpmy ,

Zacks Investment Research Upgrades Astellas Pharma (OTCMKTS:ALPMY) to Hold

Astellas Pharma (OTCMKTS:ALPMY – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for […] ....

Betanis Myrbetriq , Astellas Pharma , Advagraf Graceptor , Jefferies Financial Group , Astellas Pharma Inc , Zacks Investment Research , Astellas Pharma Company Profile Get Rating , Get Rating , Financial Group , Pharma Company Profile , Pharma Inc , Otcmkts Alpmy ,